This case of non-nodal mantle cell lymphoma (MCL) showcases atypical hairy cell-like features, distinguishing it via next-generation sequencing. Despite a TP53 mutation indicating poor prognosis, our case followed an indolent course, highlighting the importance of genetic testing and phenotypical examination in MCL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109038 | PMC |
| http://dx.doi.org/10.1002/ccr3.8869 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Central nervous system involvement by non-nodal mantle cell lymphoma masquerading as autoimmune encephalitis versus paraneoplastic syndrome.
J Neuropathol Exp Neurol
December 2024
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States.
This case of non-nodal mantle cell lymphoma (MCL) showcases atypical hairy cell-like features, distinguishing it via next-generation sequencing. Despite a TP53 mutation indicating poor prognosis, our case followed an indolent course, highlighting the importance of genetic testing and phenotypical examination in MCL.
View Article and Find Full Text PDFDevelopment of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma.
Ann Hematol
August 2024
Department of Hematology, Kochi Medical School, Kochi University, Nankoku, 783-8505, Kochi, Japan.
Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
Hum Pathol
February 2024
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Optical genome mapping (OGM) is a new DNA-based technology which provides comprehensive examination of the entire genome. We report two patients who presented with splenomegaly and leukocytosis with lymphocytosis including villous lymphocytes. Neither patient had lymphadenopathy.
View Article and Find Full Text PDFLeukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement.
Ann Hematol
February 2024
Section of Pathology, Translational Science & Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!